Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: GUTS

Fractyl Health, Inc. Common Stock

Healthcare | Biotechnology

No licensed closing price on file for GUTS. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Fractyl Health, Inc. Common Stock (NASDAQ: GUTS) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 12:30 UTC.

What Fractyl Health, Inc. Common Stock does

The company is a clinical-stage metabolic therapeutics developer focused on treating obesity and type 2 diabetes through novel approaches targeting root causes rather than chronic symptom management. Its lead product candidate, Revita, uses hydrothermal ablation to remodel the duodenal lining and help patients maintain weight loss after discontinuing GLP-1 therapy, and has received FDA Breakthrough Device designation.

Summarized from Fractyl Health, Inc. Common Stock’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
Return on equity-241.68%

Revenue, margins & earnings

FY2023: net loss $77M on revenue $120,000$120,000FY2023FY2024: net loss $69M on revenue $93,000$93,000FY2024
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-16
  • 2026-09-16DirectorPurchase64,516$39.9K
  • 2026-06-15DirectorPurchase23,000$19.6K
  • 2026-06-11Chief Executive OfficerPurchase25,000$18.3K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Fractyl Health, Inc. Common Stock do?

The company is a clinical-stage metabolic therapeutics developer focused on treating obesity and type 2 diabetes through novel approaches targeting root causes rather than chronic symptom management.

When did GUTS last file with the SEC?

Fractyl Health, Inc. Common Stock's most recent SEC filing on record is a 8-K filed 2026-10-16. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 12:30 UTC. This page is also available as JSON at /api/data?ticker=GUTS and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for GUTS and 5,000+ tickers.

Create a free account — keep GUTS
For your agent
GET /api/data?ticker=GUTS

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt